Identification and characterization of chlorin e(4) ethyl ester in sera of individuals participating in the chlorophyllin chemoprevention trial - PubMed (original) (raw)
Clinical Trial
doi: 10.1021/tx000069k.
Affiliations
- PMID: 10995263
- DOI: 10.1021/tx000069k
Clinical Trial
Identification and characterization of chlorin e(4) ethyl ester in sera of individuals participating in the chlorophyllin chemoprevention trial
P A Egner et al. Chem Res Toxicol. 2000 Sep.
Abstract
Chlorophyllin (CHL), a mixture of water soluble derivatives of chlorophyll, has been shown to be an effective inhibitor of aflatoxin B(1) (AFB(1)) carcinogenesis and AFB(1)-DNA adduct formation in rainbow trout and rats [Breinholt, V., Hendricks, J., Pereira, C., Arbogast, D., and Bailey, G. (1995) Cancer Res. 55, 57-62; Kensler, T. W., Groopman, J. D., and Roebuck, B. D. (1998) Mutat. Res. 402, 165-172]. The chemopreventive action of CHL has been previously attributed to molecular complexing. In 1997, a randomized, double-blind clinical trial of CHL was conducted in Qidong, Jiangsu Province, People's Republic of China. At the completion of the study, when serum samples were regrouped by subject identification number, it was noted that many of the participant samples were green in color. Using HPLC, ESI/MS, and MS/MS techniques, serum samples from individuals receiving CHL were found to contain previously unreported copper chlorin e(4) ethyl ester (CuCle(4) ethyl ester) as well as copper chlorin e(4) (CuCle(4)). Both chlorins originated in the study tablet, were absorbed into the bloodstream, and conferred a green color to the sera. This initial finding of in vivo absorption and bioavailability of two chlorin derivatives suggests that the mechanism of CHL chemoprevention may lie in the actions of these two components in vivo in addition to preventing carcinogen absorption from the gut.
Similar articles
- Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.
Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. Egner PA, et al. Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14601-6. doi: 10.1073/pnas.251536898. Epub 2001 Nov 27. Proc Natl Acad Sci U S A. 2001. PMID: 11724948 Free PMC article. Clinical Trial. - Mechanisms of chlorophyllin anticarcinogenesis against aflatoxin B1: complex formation with the carcinogen.
Breinholt V, Schimerlik M, Dashwood R, Bailey G. Breinholt V, et al. Chem Res Toxicol. 1995 Jun;8(4):506-14. doi: 10.1021/tx00046a004. Chem Res Toxicol. 1995. PMID: 7548730 - Chlorophyllin chemoprevention in trout initiated by aflatoxin B(1) bath treatment: An evaluation of reduced bioavailability vs. target organ protective mechanisms.
Breinholt V, Arbogast D, Loveland P, Pereira C, Dashwood R, Hendricks J, Bailey G. Breinholt V, et al. Toxicol Appl Pharmacol. 1999 Jul 15;158(2):141-51. doi: 10.1006/taap.1999.8696. Toxicol Appl Pharmacol. 1999. PMID: 10406929 - Chemopreventive properties of chlorophylls towards aflatoxin B1: a review of the antimutagenicity and anticarcinogenicity data in rainbow trout.
Dashwood R, Negishi T, Hayatsu H, Breinholt V, Hendricks J, Bailey G. Dashwood R, et al. Mutat Res. 1998 Mar 20;399(2):245-53. doi: 10.1016/s0027-5107(97)00259-5. Mutat Res. 1998. PMID: 9672663 Review. - The rainbow trout liver cancer model: response to environmental chemicals and studies on promotion and chemoprevention.
Williams DE. Williams DE. Comp Biochem Physiol C Toxicol Pharmacol. 2012 Jan;155(1):121-7. doi: 10.1016/j.cbpc.2011.05.013. Epub 2011 Jun 16. Comp Biochem Physiol C Toxicol Pharmacol. 2012. PMID: 21704190 Free PMC article. Review.
Cited by
- Carotenoids and Chlorophylls as Antioxidants.
Pérez-Gálvez A, Viera I, Roca M. Pérez-Gálvez A, et al. Antioxidants (Basel). 2020 Jun 9;9(6):505. doi: 10.3390/antiox9060505. Antioxidants (Basel). 2020. PMID: 32526968 Free PMC article. Review. - Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls.
Dashwood RH. Dashwood RH. Genes Environ. 2021 Mar 6;43(1):8. doi: 10.1186/s41021-021-00180-8. Genes Environ. 2021. PMID: 33676582 Free PMC article. Review. - Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers.
Jubert C, Mata J, Bench G, Dashwood R, Pereira C, Tracewell W, Turteltaub K, Williams D, Bailey G. Jubert C, et al. Cancer Prev Res (Phila). 2009 Dec;2(12):1015-22. doi: 10.1158/1940-6207.CAPR-09-0099. Epub 2009 Dec 1. Cancer Prev Res (Phila). 2009. PMID: 19952359 Free PMC article. - In Vitro Bioaccessibility Protocol for Chlorophylls.
Viera I, Herrera M, Roca M. Viera I, et al. J Agric Food Chem. 2021 Aug 11;69(31):8777-8786. doi: 10.1021/acs.jafc.1c02815. Epub 2021 Jul 30. J Agric Food Chem. 2021. PMID: 34328725 Free PMC article. - Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.
Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. Egner PA, et al. Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14601-6. doi: 10.1073/pnas.251536898. Epub 2001 Nov 27. Proc Natl Acad Sci U S A. 2001. PMID: 11724948 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources